Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$31.15 - $33.39 $2,398 - $2,571
77 Added 59.23%
207 $6,000
Q1 2022

May 13, 2022

SELL
$19.97 - $26.94 $539 - $727
-27 Reduced 17.2%
130 $3,000
Q4 2021

Feb 14, 2022

BUY
$17.46 - $21.61 $349 - $432
20 Added 14.6%
157 $3,000
Q3 2021

Oct 29, 2021

BUY
$17.35 - $22.5 $1,197 - $1,552
69 Added 101.47%
137 $3,000
Q2 2021

Aug 06, 2021

BUY
$18.01 - $28.32 $18 - $28
1 Added 1.49%
68 $2,000
Q1 2021

May 10, 2021

BUY
$19.76 - $29.89 $59 - $89
3 Added 4.69%
67 $2,000
Q4 2020

Feb 09, 2021

BUY
$15.73 - $21.66 $125 - $173
8 Added 14.29%
64 $1,000
Q1 2020

May 05, 2020

BUY
$5.57 - $11.5 $311 - $644
56 New
56 $0
Q3 2019

Nov 05, 2019

SELL
$9.17 - $12.01 $770 - $1,008
-84 Closed
0 $0
Q2 2019

Aug 06, 2019

SELL
$10.88 - $17.6 $968 - $1,566
-89 Reduced 51.45%
84 $1,000
Q1 2019

May 01, 2019

BUY
$15.51 - $17.61 $2,016 - $2,289
130 Added 302.33%
173 $3,000
Q3 2017

Oct 27, 2017

BUY
$13.45 - $14.35 $578 - $617
43
43 $1,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.